The Centre for Commercialization of Regenerative Medicine (CCRM): CCRM Announces Its Inaugural Board of Directors

TORONTO, ONTARIO, Sep 28 (MARKET WIRE) --
The Centre for Commercialization of Regenerative Medicine (CCRM) is proud
to announce its inaugural Board of Directors. The Board represents
extensive experience in company creation, international academic
excellence and seasoned leaders sourced from the regenerative medicine
industry. Chaired by Greg Bonfiglio, Managing Partner of Proteus Venture
Partners, the Board is poised to establish CCRM as an international
leader in regenerative medicine commercialization.

Michael May, CEO of CCRM, is delighted with the caliber of the Board, "We
are proud to be working with this accomplished group of regenerative
medicine leaders". May adds, "It is a reflection of the level of interest
in the capital-efficient commercialization model offered by CCRM."

-- Greg Bonfiglio (Chair), Managing Partner of Proteus Venture Partners
-- Melissa Carpenter, President, Carpenter Group, Stem Cell Strategies
-- Allen Eaves, Founder, President and CEO of Stemcell Technologies Inc.
-- Rafi Hofstein, President and CEO of MaRS Innovation
-- Peter Lewis, Associate Vice President, Research at the University of
Toronto
-- Michael May, CEO of Centre for Commercialization of Regenerative
Medicine
-- Geoff MacKay, President and CEO of Organogenesis
-- Ruth McKernan, Senior Vice President of Pfizer Research U.K.
-- Stephen Minger, Global Director for Research and Development for Cell
Technologies, GE Healthcare, UK
-- Lita Nelsen, Director of Technology Licensing Office, Massachusetts
Institute of Technology
-- Christopher Paige, Vice President, Research, University Health Network
-- Duncan Stewart, CEO and Scientific Director, Ottawa Hospital Research
Institute
-- Peter Zandstra, CSO of Centre for Commercialization of Regenerative
Medicine

CCRM, a Canadian not-for-profitorganization, supports the development of
technologies that accelerate the commercialization of stem cell- and
biomaterials-based technologies and therapies.A network of academics,
industry and entrepreneurs, CCRM translates scientific discoveries into
marketable products for patients. CCRM launched in Toronto's Discovery
District on June 14, 2011.

Contacts:
The Centre for Commercialization of Regenerative Medicine
Sandra Donaldson
Manager, Communications
416.978.0553 or Cell: 647.926.1228
sandra.donaldson@ccrm.ca
www.ccrm.ca

Copyright 2011, Market Wire, All rights reserved.

-0-